Scarica l'app Stockscreener
31.28
0.86%
-0.27
Dopo l'orario di chiusura:
31.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RARE Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$31.55
Aprire:
$31.63
Volume 24 ore:
1.40M
Relative Volume:
0.75
Capitalizzazione di mercato:
$3.01B
Reddito:
$522.75M
Utile/perdita netta:
$-558.99M
Rapporto P/E:
-4.8346
EPS:
-6.47
Flusso di cassa netto:
$-439.53M
1 W Prestazione:
+3.23%
1M Prestazione:
+9.91%
6M Prestazione:
-23.89%
1 anno Prestazione:
-44.26%
Intervallo 1D:
$31.03
$31.92
Intervallo di 1 settimana:
$29.71
$32.58
Portata 52W:
$25.81
$60.37
Ultragenyx Pharmaceutical Inc Stock (RARE) Company Profile
Nome
Ultragenyx Pharmaceutical Inc
Settore
Industria
Telefono
415-483-8800
Indirizzo
60 LEVERONI COURT, NOVATO, CA
Confronta RARE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RARE
Ultragenyx Pharmaceutical Inc
|
31.28 | 3.09B | 522.75M | -558.99M | -439.53M | -6.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ultragenyx Pharmaceutical Inc Stock (RARE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-28 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-28 | Iniziato | William Blair | Outperform |
| 2024-06-06 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-04-22 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-06-14 | Ripresa | Credit Suisse | Outperform |
| 2023-06-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-04-26 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-18 | Ripresa | Canaccord Genuity | Buy |
| 2022-12-30 | Ripresa | H.C. Wainwright | Buy |
| 2022-11-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-10-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-08-01 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-03-16 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2022-02-11 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-09-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-08-19 | Iniziato | UBS | Sell |
| 2021-07-15 | Iniziato | Guggenheim | Neutral |
| 2021-06-29 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-06-04 | Ripresa | Robert W. Baird | Neutral |
| 2021-05-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-05-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Neutral |
| 2021-03-02 | Ripresa | Stifel | Buy |
| 2021-02-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2020-11-24 | Ripresa | Evercore ISI | In-line |
| 2020-11-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2019-08-02 | Ripresa | Wedbush | Outperform |
| 2019-03-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-02-22 | Ripresa | Raymond James | Outperform |
| 2019-01-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2018-11-08 | Aggiornamento | Citigroup | Sell → Neutral |
| 2018-09-10 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-06-21 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-05-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-05-10 | Iniziato | Goldman | Neutral |
| 2018-04-18 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-03-22 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-21 | Reiterato | Stifel | Buy |
| 2018-01-22 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-01-18 | Iniziato | Credit Suisse | Outperform |
| 2017-12-05 | Reiterato | Barclays | Equal Weight |
| 2017-12-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2017-09-14 | Aggiornamento | Wedbush | Neutral → Outperform |
Mostra tutto
Ultragenyx Pharmaceutical Inc Borsa (RARE) Ultime notizie
What earnings revisions data tells us about Ultragenyx Pharmaceutical Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
What indicators show strength in Ultragenyx Pharmaceutical Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser
What does recent volatility data suggest for Ultragenyx Pharmaceutical Inc.2025 Bull vs Bear & Comprehensive Market Scan Reports - Newser
How to build a dashboard for Ultragenyx Pharmaceutical Inc. stock2025 Big Picture & Safe Entry Zone Identification - Newser
Trend analysis for Ultragenyx Pharmaceutical Inc. this weekQuarterly Profit Summary & Low Drawdown Trading Techniques - Newser
How to interpret RSI for Ultragenyx Pharmaceutical Inc. stockMarket Performance Report & Long-Term Capital Growth Strategies - Newser
Real time scanner hits for Ultragenyx Pharmaceutical Inc. explainedWeekly Profit Analysis & Consistent Return Investment Signals - Newser
How hedge fund analytics apply to Ultragenyx Pharmaceutical Inc. stockShort Setup & Weekly Chart Analysis and Guides - Newser
Will earnings trigger a reversal in Ultragenyx Pharmaceutical Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - Newser
Institutional scanner results for Ultragenyx Pharmaceutical Inc.2025 Valuation Update & Precise Buy Zone Identification - Newser
Top chart patterns to watch in Ultragenyx Pharmaceutical Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - Newser
Quantitative breakdown of Ultragenyx Pharmaceutical Inc. recent moveCEO Change & Entry Point Confirmation Signals - Newser
Ultragenyx Pharmaceutical Inc. stock trend forecastInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Ultragenyx Pharmaceutical Inc. stock daily chart insightsLong Setup & Reliable Breakout Stock Forecasts - Newser
Is Ultragenyx Pharmaceutical Inc. stock good for income investorsJuly 2025 Rallies & Weekly Market Pulse Alerts - khodrobank.com
Real time pattern detection on Ultragenyx Pharmaceutical Inc. stockMarket Movement Recap & Risk Controlled Swing Trade Alerts - Newser
Can Ultragenyx Pharmaceutical Inc. ride the EV waveTrade Exit Summary & AI Optimized Trading Strategy Guides - khodrobank.com
What’s the outlook for Ultragenyx Pharmaceutical Inc.’s sectorPortfolio Growth Summary & Weekly Market Pulse Updates - khodrobank.com
Applying sector rotation models to Ultragenyx Pharmaceutical Inc.CPI Data & Proven Capital Preservation Methods - Newser
Published on: 2025-09-02 13:45:06 - Newser
What machine learning models say about Ultragenyx Pharmaceutical Inc.Earnings Trend Report & Precise Swing Trade Entry Alerts - Newser
Pomerantz LLP Investigates Claims Against Ultragenyx Pharmaceutical Inc. - AInvest
Reversal indicators forming on Ultragenyx Pharmaceutical Inc. stock2025 Market Overview & Real-Time Buy Signal Notifications - Newser
Ultragenyx Pharmaceutical Inc. recovery potential after sell offCEO Change & Daily Market Momentum Tracking - Newser
Full technical analysis of Ultragenyx Pharmaceutical Inc. stockWeekly Stock Summary & AI Forecast Swing Trade Picks - Newser
Is Ultragenyx Pharmaceutical Inc. being accumulated by smart moneyCPI Data & Weekly High Momentum Picks - khodrobank.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc.RARE - Your Wyoming Link
Does Ultragenyx Pharmaceutical Inc. outperform in volatile marketsJuly 2025 Market Mood & High Accuracy Trade Alerts - خودرو بانک
Published on: 2025-09-01 02:49:16 - Newser
Published on: 2025-08-31 23:35:05 - Newser
Ultragenyx Pharmaceutical Inc. stock trendline breakdownJuly 2025 Selloffs & Accurate Technical Buy Alerts - Newser
Ultragenyx Pharmaceutical Inc. stock outlook for YEARJuly 2025 Update & High Accuracy Trade Alerts - Newser
Custom watchlist performance reports with Ultragenyx Pharmaceutical Inc.M&A Rumor & AI Driven Price Forecasts - Newser
What Fibonacci levels say about Ultragenyx Pharmaceutical Inc. reboundEarnings Miss & Weekly Watchlist of Top Performers - Newser
Applying big data sentiment scoring on Ultragenyx Pharmaceutical Inc.Quarterly Growth Report & AI Forecast Swing Trade Picks - Newser
Intraday pattern recognizer results for Ultragenyx Pharmaceutical Inc.2025 Bull vs Bear & Safe Swing Trade Setups - Newser
News impact scoring models applied to Ultragenyx Pharmaceutical Inc.Weekly Trade Report & Safe Capital Growth Trade Ideas - Newser
Ultragenyx Pharmaceutical Inc Azioni (RARE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):